Safety of high-dose intravitreal triamcinolone acetonide as low-cost alternative to anti-vascular endothelial growth factor agents in lower-middle-income countries.

Safety of high-dose intravitreal triamcinolone acetonide as low-cost alternative to anti-vascular endothelial growth factor agents in lower-middle-income countries. — المؤلف: Ghoraba, Hammouda Hamdy — Clinical ophthalmology (Auckland, N.Z.) 2018

المؤلف
Ghoraba, Hammouda Hamdy
النشر
Clinical ophthalmology (Auckland, N.Z.) 2018
الوصف
2383-2391 p.